Skip to main content
Premium Trial:

Request an Annual Quote

Streck, Nordic BioSite Ink Distribution Deal

NEW YORK (GenomeWeb) – Streck and Nordic BioSite have signed a distribution deal for Streck's full portfolio of cell stabilization, molecular, and core products.

Nordic BioSite is a life sciences products distributor in Sweden, Finland, Denmark, and Norway.

Streck's cell stabilization products include Cell-Free DNA Urine Preserve, a formaldehyde-free liquid reagent that stabilizes cell-free DNA in urine; Cyto-Chex BCT, a blood collection tube for preserving whole blood specimens for immunophenotyping by flow cytometry; Cell-Free DNA BCTa direct-draw blood collection tube which stabilizes nucleated blood cells and prevents the release of genomic DNA, allowing isolation of cell-free DNA for a wide range of downstream applications; and Cell-Free RNA BCTa blood collection tube that stabilizes circulating RNA in plasma and prevents the release of non-target background RNA from blood cells during sample processing and storage.

"We are pleased to represent Streck throughout Scandinavia and the Baltic States and conveniently supply clinicians and life science researchers with Streck's product ranges," Nordic BioSite CEO Yvonne Zar said in a statement.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.